We Can Do This!
We Can Do This!
Dec 1, 2021
15: The Drug Pricing Middlemen Driving up Drug Costs
Play • 47 min

Healthcare continues to be front and center in the national discourse, particularly in the midst of the pandemic. As Congress works on policy solutions to lower healthcare costs for consumers, we face an unfair disadvantage when it comes to what we’re paying at the pharmacy counter. Many consumers don’t know that this is largely due to middlemen companies called pharmacy benefit managers (PBMs).

 Antonio Ciaccia, President of 3Axis Advisors and Chief Executive Officer of 46brooklyn Research, joins NCL’s Executive Director Sally Greenberg to talk about the role PBMs play in our drug pricing system and how they impact what consumers pay out-of-pocket for their medicines.


*Due to COVID-19 safety protocols, this episode was recorded remotely. Audio quality may not be consistent throughout.*

More episodes
Clear search
Close search
Google apps
Main menu